Hypercapnia in COPD: Causes, Consequences, and Therapy

72Citations
Citations of this article
239Readers
Mendeley users who have this article in their library.

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder that may lead to gas exchange abnormalities, including hypercapnia. Chronic hypercapnia is an independent risk factor of mortality in COPD, leading to epithelial dysfunction and impaired lung immunity. Moreover, chronic hypercapnia affects the cardiovascular physiology, increases the risk of cardiovascular morbidity and mortality, and promotes muscle wasting and musculoskeletal abnormalities. Noninvasive ventilation is a widely used technique to remove carbon dioxide, and several studies have investigated its role in COPD. In the present review, we aim to summarize the causes and effects of chronic hypercapnia in COPD. Furthermore, we discuss the use of domiciliary noninvasive ventilation as a treatment option for hypercapnia while highlighting the controversies within the evidence. Finally, we provide some insightful clinical recommendations and draw attention to possible future research areas.

Cite

CITATION STYLE

APA

Csoma, B., Vulpi, M. R., Dragonieri, S., Bentley, A., Felton, T., Lázár, Z., & Bikov, A. (2022, June 1). Hypercapnia in COPD: Causes, Consequences, and Therapy. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm11113180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free